Back to Trades
Teleman Dan Benjamin
Chief Executive OfficerDirectorCIK 0002122500
Profile
- Filings
- 5
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Teleman Dan Benjamin, Chief Executive Officer, Director, accounts for 5 disclosed filings worth $61.8K, all concentrated in Nasus Pharma Ltd (NSRX), active 2026. The record is heavily weighted toward buying, with $61.8K in purchases against $0 in sales. The largest single open-market purchase on record is $30.6K in Nasus Pharma Ltd. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 29 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Other | $0 |
| Jun 22 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $20.3K |
| Apr 22 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $10.9K |
| Apr 1 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $30.6K |
| Mar 27 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Other | $0 |
5 filings